Sirion Therapeutics, Inc.

🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2005-01-01
- Employees
- 101
- Market Cap
- -
Clinical Trials
15
Active:0
Completed:15
Trial Phases
2 Phases
Phase 2:4
Phase 3:11
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials
Phase 3
11 (73.3%)Phase 2
4 (26.7%)Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2011-07-01
- Lead Sponsor
- Sirion Therapeutics, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT00616993
- Locations
- 🇺🇸
Eye Associates of Fort Myers, Fort Myers, Florida, United States
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2011-06-30
- Lead Sponsor
- Sirion Therapeutics, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT00616070
- Locations
- 🇺🇸
Charlotte Eye, Ear, Nose & Throat, Charlotte, North Carolina, United States
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)
Phase 3
Completed
- Conditions
- Dry Eye Syndromes
- First Posted Date
- 2007-10-25
- Last Posted Date
- 2007-10-25
- Lead Sponsor
- Sirion Therapeutics, Inc.
- Registration Number
- NCT00549289
- Locations
- 🇺🇸
Clayton Eye Center, Morrow, Georgia, United States
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)
Phase 3
Completed
- Conditions
- Dry Eye Syndromes
- First Posted Date
- 2007-10-23
- Last Posted Date
- 2011-07-01
- Lead Sponsor
- Sirion Therapeutics, Inc.
- Registration Number
- NCT00548301
- Locations
- 🇺🇸
Eye Center Northeast, Bangor, Maine, United States
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)
Phase 3
Completed
- Conditions
- Dry Eye Syndromes
- First Posted Date
- 2007-07-17
- Last Posted Date
- 2011-07-01
- Lead Sponsor
- Sirion Therapeutics, Inc.
- Registration Number
- NCT00502073
- Locations
- 🇺🇸
Eye Center Northeast, Bangor, Maine, United States
- Prev
- 1
- 2
- 3
- Next
News
No news found